Glenmark Pharmaceuticals Celebrates Inauguration of $100 Million Facility in Monroe, N.C.

MONROE, N.C.  – Glenmark Pharmaceuticals, a global innovative pharmaceutical company with operations in more than 50 countries, will hold an inauguration ceremony of its manufacturing facility built in Monroe, N.C. on Tuesday, October 30, at 10:30 a.m. 

The Monroe facility is Glenmark’s first manufacturing site in the United States and currently has nearly 140 employees at the site.  Glenmark has invested over $100 million into the facility so far, with plans for further expansion in the coming years. Partnering with South Piedmont Community College, Glenmark has helped design and fund a training program to further educational and growth opportunities for all employees, with courses focused on advanced technical skills, safety, leadership, and process improvement tools.

The inauguration ceremony will include remarks from:

David Greeley, Executive Director & Monroe Site Head of Operations, Glenmark

Robert Matsuk, President, North America and Global API, Glenmark

Pat Kahle, President, Union County Chamber of Commerce

**Additional VIPs will be announced

WHAT:            Inauguration of Glenmark Pharmaceuticals Manufacturing Facility

WHEN:            Tuesday, October 30, 2018

                        10:30 am EDT

WHERE:         Glenmark Pharmaceuticals

                        4147 Goldmine Road

                        Monroe, N.C. 28110

Credentialed members of the media interested in attending the inauguration event or learning more about Glenmark’s investment into the United States and North Carolina should contact Cassie Scher at (202) 441-6201,cassie@nahigianstrategies.com.  Additional details will be provided upon registration.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (GPL) is a global innovative pharmaceutical company with operations in more than 50 countries. Glenmark has a diverse pipeline with several compounds in various stages of clinical development, primarily focused in the areas of oncology, respiratory disease and dermatology. Glenmark has improved the lives of millions of patients by offering safe, affordable medications for nearly 40 years. For more information, visit glenmarkpharma-us.com.

Back to news